Loading…
Polyrizon Ltd. is projected to decline to $14.02 by 2027, a -15% move from its current price of $16.49. PLRZ is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $15.53 | $16.48 | $17.50 | -0.04% |
| May 30 | $15.14 | $16.48 | $17.93 | -0.08% |
| May 31 | $14.85 | $16.47 | $18.27 | -0.12% |
| Jun 1 | $14.61 | $16.46 | $18.56 | -0.16% |
| Jun 2 | $14.40 | $16.46 | $18.82 | -0.19% |
| Jun 3 | $14.21 | $16.45 | $19.05 | -0.23% |
| Jun 4 | $14.04 | $16.45 | $19.27 | -0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.04 | $16.45 | $19.27 | -0.27% |
| Week 2 | $13.11 | $16.40 | $20.52 | -0.54% |
| Week 3 | $12.43 | $16.36 | $21.52 | -0.81% |
| Week 4 | $11.88 | $16.31 | $22.39 | -1.08% |
| Week 5 | $11.41 | $16.27 | $23.18 | -1.35% |
| Week 6 | $11.00 | $16.22 | $23.92 | -1.62% |
| Week 7 | $10.64 | $16.18 | $24.61 | -1.88% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Polyrizon Ltd. is a biotech company focused on developing medical device hydrogels in the form of nasal sprays in Israel. It uses its proprietary technology to develop products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients.
It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 and is headquartered in Ra\'anana, Israel.
Polyrizon Ltd. (PLRZ) is the asset traded in the Healthcare sector with a current price of $16.49 and a market cap of $30.87M. It holds a rank of 4744 among tracked assets.
The forecasted price trajectory shows variability across years, with a flat 2026 average price of $16.49 and range of potential outcomes up to $22.65, then a course of movement through 2030 with an average around $14.65 and a peak in 2050 near $45.05. The long-run outlook includes a 2050 average price of $45.05 and a 173.2% ROI, signaling substantial upside potential in the later horizon.
Across the intermediate years, the forecast includes positive momentum in 2032 (avg $20.36, ROI 23.5) and a strong rise by 2040 (avg $23.47, ROI 42.3), reinforcing a multi-year path to higher prices despite earlier fluctuations.
A major floor 45.4% below — a decisive break under it would weaken the trend.
The nearest floor, 33.7% below — buyers have tended to step in here.
Price is pressing into resistance (0.8% away) — a breakout level to watch.
A major ceiling 23.6% above — clearing it would confirm fresh momentum.
Key PLRZ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PLRZ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.80 | Buy | $15.37 | Buy |
| MA 10 | $14.67 | Buy | $14.99 | Buy |
| MA 20 | $14.99 | Buy | $14.73 | Buy |
| MA 50 | $13.73 | Buy | $14.09 | Buy |
| MA 100 | $13.76 | Buy | $19.46 | Sell |
| MA 200 | $10.28 | Buy | $125.96 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.26 | Neutral |
| Stoch RSI (14) | 89.88 | Sell |
| CCI (20) | 115.98 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 0.92 | Buy |
| Bollinger %B (20,2) | 0.86 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.36 | Buy |
| Awesome (5,34) | 0.68 | Buy |
| Ultimate (7,14,28) | 62.25 | Neutral |
| Momentum (10) | 1.48 | Buy |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 15.72 | Buy |
| ADX (14) | 14.73 | Neutral |
| ATR (14) | 0.73 | Info |
The 30-day technical picture is bullish with an RSI of 60. The 50-day simple moving average is $13.73, above the 200-day simple moving average of $10.28, which can be read as supportive of potential upside.
Support is listed at $10.89 and resistance at $16.63, framing near-term price limits. The 30-day range spans from $11.11 to $24.47, indicating a broad fluctuating window for the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.75 | $16.49 | $22.65 | 0% | Neutral | |
| $10.09 | $14.02 | $21.08 | -15% | Neutral | |
| $9.59 | $14.14 | $22.60 | -14% | Neutral | |
| $8.57 | $13.30 | $22.29 | -19% | Bearish | |
| $9.01 | $14.65 | $25.54 | -11% | Neutral | |
| $11.44 | $19.45 | $35.08 | +18% | Neutral | |
| $11.49 | $20.36 | $37.85 | +23% | Bullish | |
| $10.57 | $19.50 | $37.24 | +18% | Neutral | |
| $8.68 | $16.66 | $32.61 | +1% | Neutral | |
| $7.93 | $15.82 | $31.69 | -4% | Neutral | |
| $10.56 | $23.47 | $51.62 | +42% | Bullish | |
| $20.27 | $45.05 | $103.61 | +173% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $10.75 | $16.49 | $19.68 | +0.00% |
| June 2026 | $13.71 | $16.44 | $20.43 | -0.31% |
| July 2026 | $13.05 | $15.92 | $20.29 | -3.17% |
| August 2026 | $13.47 | $16.65 | $21.64 | +4.62% |
| September 2026 | $13.65 | $17.06 | $22.51 | +2.45% |
| October 2026 | $12.72 | $16.06 | $21.49 | -5.88% |
| November 2026 | $12.32 | $15.70 | $21.26 | -2.24% |
| December 2026 | $12.86 | $16.53 | $22.65 | +5.32% |
Click any year to see its month-by-month PLRZ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PLRZ is projected to trade between $10.75 and $22.65, averaging $16.49 — a potential gain of 0% from today's $16.49. A consolidation phase looks the most probable path here.
Polyrizon Ltd.'s 2027 outlook centres on $14.02, within a $10.09 to $21.08 range. That is -15% versus the projected 2026 average. That marks a -15% change versus current levels. Price action looks broadly range-bound.
By 2028, PLRZ could reach as high as $22.60, with a base case around $14.14 and support toward $9.59 — roughly -14% from $16.49. A consolidation phase looks the most probable path here.
Expect PLRZ to range from $8.57 to $22.29 through 2029. The $13.30 average target implies a -19% move from current prices. That is -6% versus the projected 2028 average. A cyclical pullback looks likely — prices rarely move in a straight line.
The PLRZ price prediction for 2030 points to an average of $14.65 (low $9.01, high $25.54) — a potential decline of -11% on today's $16.49. A consolidation phase looks the most probable path here.
In 2031, PLRZ is projected to trade between $11.44 and $35.08, averaging $19.45 — a potential gain of +18% from today's $16.49. That is up +33% on the projected 2030 average. Price action looks broadly range-bound.
Polyrizon Ltd.'s 2032 outlook centres on $20.36, within a $11.49 to $37.85 range. That is up +5% on the projected 2031 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PLRZ could reach as high as $37.24, with a base case around $19.50 and support toward $10.57 — roughly +18% from $16.49. Price action looks broadly range-bound.
Expect PLRZ to range from $8.68 to $32.61 through 2034. The $16.66 average target implies a +1% move from current prices. That is -15% versus the projected 2033 average. A consolidation phase looks the most probable path here.
The PLRZ price prediction for 2035 points to an average of $15.82 (low $7.93, high $31.69) — a potential decline of -4% on today's $16.49. Price action looks broadly range-bound.
In 2040, PLRZ is projected to trade between $10.56 and $51.62, averaging $23.47 — a potential gain of +42% from today's $16.49. That is up +48% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Polyrizon Ltd.'s 2050 outlook centres on $45.05, within a $20.27 to $103.61 range. That is up +92% on the projected 2040 average. That marks a +173% change versus current levels. Momentum favours further upside here.
Investing $1,000 in PLRZ today (≈ 60.642814 PLRZ) could be worth
$2,731.84
+$1,731.84 (+173%) by 2050 · US Dollar
Based on the average projected PLRZ price of $45.05 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PLRZwould be worth at today's price.
$1,000 invested in PLRZ on May 27, 2025 (≈ 257.997941 PLRZ) would be worth
$4,254.39
+$3,254.39 (+325.4%) today · 4.25× · US Dollar
Based on a PLRZ entry price of $3.88 vs. today's $16.49.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.55 | $1,216.97 | +21.7% |
| 1 month ago | $16.63 | $991.58 | -0.8% |
| 3 months ago | $13.69 | $1,204.53 | +20.5% |
| 6 months ago | $3.21 | $5,137.07 | +413.7% |
| 1 year ago | $3.88 | $4,254.39 | +325.4% |
| All time (1.6y) ago | $2,325 | $7.09 | -99.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PLRZ forecast.
Our base-case forecast reaches $33.00 around 2050.
Implied market cap at $33.00: $61.77M
The multi-year forecast spans 2026 to 2050. In 2030 the average price is $14.65 with a -11.2% ROI and neutral sentiment, highlighting a mid-cycle dip. By 2032 the average rises to $20.36 with a 23.5% ROI and bullish lean, followed by a 2040 forecast of $23.47 average price and a 42.3% ROI with bullish sentiment.
By 2050 the average price is projected at $45.05 with a 173.2% ROI and bullish sentiment, reflecting the strongest long-run upside in the horizon. The forecast also shows negative near-term ROI in several years (e.g., 2027 -15%, 2028 -14.3%, 2029 -19.4%), underscoring a period of volatility before substantial long-run gains. An annualized volatility of 100% accompanies the outlook, signaling high market fluctuations.
Tap a question to reveal the answer.
The 2030 forecast shows min $9.01, avg $14.65, max $25.54 with ROI -11.2% and sentiment Neutral.
The 2050 forecast lists a max of $103.61, with an average of $45.05 and ROI 173.2% with bullish sentiment, indicating a potential approach to the $100 level within the projected range.
The long-run view suggests substantial upside by 2050 (avg $45.05, ROI 173.2%, bullish), but near-term years show negative ROI (e.g., 2027 -15%, 2028 -14.3%, 2029 -19.4%), indicating mixed prospects and notable volatility.
RSI(14) is 60, SMA50 is $13.73, SMA200 is $10.28, with support at $10.94 and resistance at $16.63. The 30-day range runs from $11.11 to $24.47.
Polyrizon engages in the development of medical device hydrogels as nasal sprays in Israel, using proprietary technology to create Capture and Contain barriers against allergens and viruses, and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14 for nasal allergies blockers and PL-16 for influenza blockers, and was incorporated in 2005 with headquarters in Ra\'anana, Israel.
Polyrizon Ltd. Community Discussion
0Share your Polyrizon Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.